(NASDAQ: BNGO) Bionano Genomics's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 30.32%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 56.59%.
Bionano Genomics's earnings in 2025 is -$83,697,000.On average, 1 Wall Street analyst forecast BNGO's earnings for 2025 to be -$34,514,640, with the lowest BNGO earnings forecast at -$34,514,640, and the highest BNGO earnings forecast at -$34,514,640.
In 2026, BNGO is forecast to generate -$17,223,680 in earnings, with the lowest earnings forecast at -$17,223,680 and the highest earnings forecast at -$17,223,680.